| Literature DB >> 24393784 |
Abstract
Limited options for clinical management of patients with juvenile-onset diabetes mellitus call for a novel therapeutic paradigm. Two innovative studies support endoplasmic reticulum as an emerging target for combating both autoimmune and heritable forms of this disease.Entities:
Mesh:
Year: 2014 PMID: 24393784 PMCID: PMC4049517 DOI: 10.1038/nrendo.2013.261
Source DB: PubMed Journal: Nat Rev Endocrinol ISSN: 1759-5029 Impact factor: 43.330